Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Inflammatory Bowel Disease Treatment Market

Inflammatory Bowel Disease Treatment Market Share

Report ID: GMI10194
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Inflammatory Bowel Disease Treatment Market Share

The inflammatory bowel disease treatment industry is characterized by the presence of several established and emerging players that offer a variety of products across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.

Inflammatory Bowel Disease Treatment Market Companies

Prominent players operating in the inflammatory bowel disease treatment industry include:

AbbVie Inc
Amgen Inc.
Biogen
CELLTRION INC
Dr Falk Pharma UK Ltd
Ferring B.V.
Ferring B.V.
Johnson & Johnson
Lilly
Novartis AG
Pfizer Inc
Takeda Pharmaceutical Company Limited
Tillotts Pharma AG
UCB Group

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Inflammatory bowel disease treatment industry size was USD 22.6 billion in 2023 and is projected to expand at 6.1% CAGR from 2024 to 2032, on account of the increasing prevalence of IBD, and growing awareness and early diagnosis of IBD symptoms.

The TNF inhibitors drug class segment in the inflammatory bowel disease treatment industry is projected to account for USD 11.1 billion by 2032, owing to their high efficacy in reducing inflammation and inducing and maintaining remission.

The injectable route of administration segment in the inflammatory bowel disease treatment industry accounted for USD 17.3 billion in 2023 and is projected to grow at notable rate between 2024 and 2032, as they are known for their high efficacy and rapid onset of action.

North America inflammatory bowel disease treatment industry recorded USD 9 billion in revenue in 2023 and is projected to grow at 5.5% CAGR from 2024 to 2032, due to its advanced healthcare infrastructure and high adoption rate of innovative inflammatory bowel disease treatment technologies.